TRINET GROUP, INC. (TNET): what the price assumes

In the published model solve dated 2026-Q2, anchored at $68.37, TRINET GROUP, INC. (TNET) is priced for +2.8% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-11.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/TNET

Headline

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

Solve inputs: computed at a 7.9% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~6.9pp.

Reconcile: at the x-ray's 9.3% required return this reads ~11.7%/yr; the models below use their own rates.

How unusual the bet is: within-range

Valuation X-Ray

The price is justified by relative-multiple and growth-DCF.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Families that justify the price: Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.9%); the inversion above states its own rate.

Per-Model Detail (n=15)

Solvency

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

• TriNet is the largest publicly traded company focused primarily on the PEO model, bundling payroll, benefits, and HR compliance for small and mid-size businesses, and its 10-K frames the health-insurance book as the profit engine: ICR is defined "as the ratio of insurance costs to insurance service revenues", which makes insurance pricing discipline, not headcount growth, the number that moves earnings.
• The biggest near-term risk is deliberate shrinkage getting away from management: average worksite employees fell 12% year over year to about 300,000 in the first quarter as clients walked from health-benefits repricing, and the bet is that the customers who stayed are the profitable ones.
• Watch the July 24, 2026 second-quarter report for whether the insurance cost ratio holds well inside the full-year 89.25% to 90.75% guidance band after the first quarter's unusually strong 84%.

Bull Case

Here is the stat that does not fit the story: revenue fell 5% in the first quarter and the stock jumped double digits on the print. That is because TriNet is running a deliberate shrink-to-profit play, repricing its health-insurance book, letting under-priced clients leave, and keeping the ones who pay for the risk they bring. GAAP net income came in at $89 million with diluted EPS of $1.90 for the quarter, and the insurance cost ratio improved more than four points year over year to 84%, roughly half from repricing and half from favorable prior-year claims development. The 10-K explains why that ratio is the whole game: management defines ICR "as the ratio of insurance costs to insurance service revenues" and tracks it as the measure of its "ability to align our relative pricing to risk performance". When the insurance book is priced right, a smaller client base earns more than a bigger, badly priced one.

Capital allocation compounds the effect. The share count has fallen about 8% a year over the past four years, and the FY2025 10-K records that "we repurchased 2,755,287 shares of our common stock for approximately $182 million" during 2025 alone, alongside a dividend recently raised to $0.29 per quarter, declared June 17, 2026 and payable July 27. Shrinking revenue divided by a faster-shrinking share count is still per-share growth. The market, meanwhile, is not asking for much: at roughly 15x operating income, the price is consistent with operating profit drifting down around 3% a year for five years. A business that merely holds earnings flat beats that bar.

The longer arc is a platform story. The filing describes "our next-generation cloud-based platform" combining the PEO and ASO stacks, "intended to further modernize our customers' experience through more self-service", and the company added leave-management capability with the $23 million Cocoon acquisition. Full-year guidance of $4.75 to $4.90 billion in revenue was reiterated with earnings expectations moving to the top half of the range on the strong insurance start. If worksite-employee counts trough in 2026 while the repriced book holds its margins, the current multiple is paying for decline that never arrives.

Bear Case

The question a PEO investor always has to ask is where the insurance cycle sits, because reported earnings here are underwriting results wearing an HR-services badge. The first quarter's 84% insurance cost ratio was the best kind of print, but half the improvement came from favorable development of 2025 claims, a one-time true-up rather than a run rate, and management's own full-year guidance band of 89.25% to 90.75% concedes the ratio reverts. The 10-K names the structural version of this risk: concentration of clients in particular regions or industries "may make it more difficult for us to obtain competitive health and/or workers' compensation insurance rates". Today's earnings sit closer to the favorable end of an insurance cycle than to a sustainable midpoint, and the price should be read against the midpoint.

The volume side is already contracting. Average worksite employees fell 12% year over year to about 300,000, driven by client attrition after the health-benefits repricing. Management calls this discipline; it is also a live experiment in how much attrition a repricing can trigger before it eats the margin gains, and every departed client lands with a competitor. The filing is candid that the competitive set is wide: direct PEO rivals, payroll processors that skip the co-employment model entirely, and the in-house HR staff of any client big enough to self-administer. ADP's PEO segment and Paychex give SMBs credible alternatives at national scale, and the cheaper software-only route gets better every year. A shrinking worksite base also concentrates the very regional exposure the 10-K warns about.

The balance sheet is serviceable rather than fortress. Net debt of $556 million runs about 2.6x trailing pre-tax operating income (on the EDGAR twelve-month basis of $217 million; a record-basis figure of $278 million diverges from it, and the two are separate measurement bases), with $340 million of liquid assets against $896 million of gross debt, and the filing flags the standard covenant machinery: in the event of noncompliance "we would seek an amendment or waiver of the covenants. We cannot assure you that any such waiver or amendment would be granted". None of that is alarming at today's coverage, but this is a business whose earnings can swing on a bad claims year, and the buyback pace that flatters per-share numbers also spends the cushion. If the insurance ratio lands at the top of guidance while worksite employees keep bleeding, the per-share arithmetic that makes the stock look cheap starts running in reverse.

Valuation

At $55.51 (July 10, 2026) the market is paying about 15x company-wide operating income, which works out to a price consistent with operating profit shrinking roughly 3% a year for the next five years. That is an undemanding bar, and it is the sharpest way to read this stock: the price already assumes decline, so the argument is about whether the decline shows up. Against the company's own recent delivery the assumption sits well inside what it has demonstrated; the stretch is only in how long any pace must persist.

The valuation methods form an unusually tight cluster around the price rather than the wide fans that growth names produce. The earnings-power and cash-flow lenses land within about 10% of the price on either side, the conservative book-value-based reads sit around 20% below it, and only the peer-multiple lens disagrees meaningfully, landing above the price, with the sector earnings multiple implying the price trades at roughly a fifth below where peers at these earnings would. The pattern says value-supported name, not growth bet: nothing about today's price requires believing in expansion, and the discount to peer multiples is the market charging for the worksite-employee attrition and the insurance-cycle reversion baked into guidance.

The per-share machinery matters more here than the enterprise numbers. Trailing EPS is $3.39, the share count has compressed about 8% a year over four years, 2025 alone saw roughly $182 million of repurchases per the 10-K, and the dividend runs $0.29 per quarter. Net debt of $556 million is about 2.6x trailing pre-tax operating income, with $340 million of liquid assets and no cash burn. Full-year 2026 guidance calls for revenue of $4.75 to $4.90 billion and an insurance cost ratio of 89.25% to 90.75%; where that ratio actually lands inside the band is the single input that decides whether the tight cluster of valuations holds or re-prices.

Catalysts

The first-quarter report, released in late April 2026, reset the story: revenue of $1.23 billion was down 5% year over year, but GAAP net income reached $89 million with diluted EPS of $1.90, and the insurance cost ratio of 84% beat expectations by enough to push full-year earnings expectations into the top half of the guidance range. Management reiterated 2026 guidance of $4.75 to $4.90 billion in total revenue, $625 to $645 million in professional services revenue, and an ICR band of 89.25% to 90.75%. The stock rose more than 10% on the print.

The capital-return calendar keeps ticking underneath: a $0.29 quarterly dividend was declared June 17, 2026, ex-dividend July 1 and payable July 27, and the company was added to the Russell 2000 Dynamic Index in the June reconstitution. The $23 million acquisition of leave-management provider Cocoon extends the benefits platform.

The next dated event is second-quarter results on July 24, 2026. Three things inside it carry the thesis: whether the insurance cost ratio's reversion toward the guidance band is orderly or abrupt, whether worksite-employee attrition decelerates from the first quarter's 12% year-over-year decline as the repricing cycle laps, and whether management sustains the buyback pace that has been converting flat enterprise results into growing per-share ones.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

• PAYX (Paychex, Inc.)
• FY2025 10-K: …noted above, total expenses increased approximately 2% compared to the prior year. Operating income: Fiscal 2025 operating income was $2.2 billion, an increase of 2% compared to fiscal 2024. Adjusted operating income (1) of $2.4 billion, which excludes the acquisition related costs and cost optimization initiatives…
• FY2025 10-K: …income, adjusted operating margin, adjusted net income, adjusted diluted earnings per share, EBITDA and adjusted EBITDA, which are non-GAAP measures. We believe these additional measures are indicators of the performance of our core business operations period over period. Adjusted operating income, adjusted operating…
• ADP (AUTOMATIC DATA PROCESSING INC)
• FY2025 10-K: …PEO Services. Certain revenues and expenses are charged to the reportable segments at a standard rate for management reasons. Other costs are recorded based on management responsibility. The Company's Chief Operating Decision Maker ("CODM") is the Chief Executive Officer. For each reportable segment, the CODM uses…
• FY2025 10-K: …expenses and the impact from the WorkForce Software acquisition. Margin Employer Services' margin increased in fiscal 2025 due to contributions from operating efficiencies for costs of servicing and implementing our clients on growing revenue, and client funds interest revenues discussed above, partially offset by…
• PAYC (Paycom Software, Inc.)
• FY2025 10-K: …condition. The market in which we participate is highly competitive, and if we do not compete effectively, our business, operating results or financial condition could be adversely affected. The market for HCM software is highly competitive, rapidly evolving and fragmented. If we are unable to compete effectively,…
• FY2025 10-K: …costs (including those related our full solution automation and AI initiatives) and general and administrative expenses, which have increased and will continue to increase our expenses. Historically, our revenue growth and geographic expansion have driven increases in (i) facility costs related to data centers, the…
• PCTY (PAYLOCITY HOLDING CORPORATION)
• FY2025 10-K: …promotion and sale of their products and services. Furthermore, our current or potential competitors may be acquired by third parties with greater available resources and the ability to initiate or withstand substantial price competition, which may include price concessions, delayed payment terms, or other terms and…
• FY2025 10-K: …we compete in our market include the following: • Solutions built to connect with today's modern workforce; • Comprehensive product suite on a single platform; • Breadth and depth of product functionality; • Configurability and ease of use of our solutions; • Modern, mobile, intuitive and consumer-oriented user…

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.